FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008329181> ?p ?o ?g. }

• W2008329181 endingPage "31" @default.
• W2008329181 startingPage "23" @default.
• W2008329181 abstract "Dendritic cell (DCs) based immunotherapy has received increased interest in the treatment of specific malignancies including breast cancer. In this in vitro study, T cell responses, which are induced by monocyte-derived DCs pulsed with apoptotic breast tumor cells (ApTC), were analyzed in terms of proliferation, specific cytotoxicity, and cytokine release. Nylon wool-enriched T lymphocytes from five patients with breast cancer stimulated with monocyte-derived DCs pulsed with apoptotic tumor cells in vitro and their proliferation response were analyzed by [(3)H] thymidine uptake and specific cytotoxic activity of tumor antigen-primed T cells after three rounds of weekly stimulation by flow cytometry. Interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) cytokine release assay was carried out 24h after the last stimulation. The supernatant from primed T cells was collected and analyzed using commercially available ELISA kits. T cell proliferation assays revealed that DCs pulsed with apoptotic tumor cell could stimulate an autologous T cell proliferation response with stimulation indices of 5-21. The T cell-mediated cytotoxicity assay demonstrated that tumor antigen-primed T cells could kill significantly more autologous tumor cells than normal cells (P<0.05). These cells had variable amounts of cytotoxic activity against K562 cells. Primed T cells released both IFN-gamma and IL-4 in response to re-stimulation by antigen-pulsed DCs, but were dominated by IFN-gamma production in two out of five patients and IL-4 production in three out of five patients. In conclusion, our results suggested that DCs pulsed with apoptotic breast tumor cells could elicit effective specific antitumor T cell responses in vitro. Therefore, vaccination with DCs pulsed with apoptotic tumor cells may be considered as a novel strategy for immunotherapy of patients with breast cancer refractory to standard modalities." @default.
• W2008329181 created "2016-06-24" @default.
• W2008329181 creator A5013906322 @default.
• W2008329181 creator A5021724355 @default.
• W2008329181 creator A5039777197 @default.
• W2008329181 creator A5050210583 @default.
• W2008329181 creator A5071896350 @default.
• W2008329181 creator A5084477865 @default.
• W2008329181 date "2009-01-01" @default.
• W2008329181 modified "2023-10-18" @default.
• W2008329181 title "Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro" @default.
• W2008329181 cites W1561591381 @default.
• W2008329181 cites W1778644925 @default.
• W2008329181 cites W1923447253 @default.
• W2008329181 cites W1966344496 @default.
• W2008329181 cites W1977945339 @default.
• W2008329181 cites W1982160787 @default.
• W2008329181 cites W1986339132 @default.
• W2008329181 cites W1989886945 @default.
• W2008329181 cites W1990943186 @default.
• W2008329181 cites W1991722469 @default.
• W2008329181 cites W1992412045 @default.
• W2008329181 cites W1995714285 @default.
• W2008329181 cites W1998082134 @default.
• W2008329181 cites W2000504443 @default.
• W2008329181 cites W2008463303 @default.
• W2008329181 cites W2010979801 @default.
• W2008329181 cites W2017591700 @default.
• W2008329181 cites W2023922986 @default.
• W2008329181 cites W2027659969 @default.
• W2008329181 cites W2028326543 @default.
• W2008329181 cites W2038284978 @default.
• W2008329181 cites W2055316167 @default.
• W2008329181 cites W2059483129 @default.
• W2008329181 cites W2072865301 @default.
• W2008329181 cites W2075012280 @default.
• W2008329181 cites W2078707797 @default.
• W2008329181 cites W2088544147 @default.
• W2008329181 cites W2092279737 @default.
• W2008329181 cites W2099467866 @default.
• W2008329181 cites W2114279767 @default.
• W2008329181 cites W2130590529 @default.
• W2008329181 cites W2134819094 @default.
• W2008329181 cites W2147269457 @default.
• W2008329181 cites W2164872597 @default.
• W2008329181 doi "https://doi.org/10.1016/j.cellimm.2009.02.002" @default.
• W2008329181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19306994" @default.
• W2008329181 hasPublicationYear "2009" @default.
• W2008329181 type Work @default.
• W2008329181 sameAs 2008329181 @default.
• W2008329181 citedByCount "35" @default.
• W2008329181 countsByYear W20083291812012 @default.
• W2008329181 countsByYear W20083291812013 @default.
• W2008329181 countsByYear W20083291812014 @default.
• W2008329181 countsByYear W20083291812015 @default.
• W2008329181 countsByYear W20083291812016 @default.
• W2008329181 countsByYear W20083291812017 @default.
• W2008329181 countsByYear W20083291812018 @default.
• W2008329181 countsByYear W20083291812019 @default.
• W2008329181 countsByYear W20083291812020 @default.
• W2008329181 countsByYear W20083291812022 @default.
• W2008329181 countsByYear W20083291812023 @default.
• W2008329181 crossrefType "journal-article" @default.
• W2008329181 hasAuthorship W2008329181A5013906322 @default.
• W2008329181 hasAuthorship W2008329181A5021724355 @default.
• W2008329181 hasAuthorship W2008329181A5039777197 @default.
• W2008329181 hasAuthorship W2008329181A5050210583 @default.
• W2008329181 hasAuthorship W2008329181A5071896350 @default.
• W2008329181 hasAuthorship W2008329181A5084477865 @default.
• W2008329181 hasConcept C147483822 @default.
• W2008329181 hasConcept C149532602 @default.
• W2008329181 hasConcept C153911025 @default.
• W2008329181 hasConcept C154317977 @default.
• W2008329181 hasConcept C202751555 @default.
• W2008329181 hasConcept C203014093 @default.
• W2008329181 hasConcept C2776090121 @default.
• W2008329181 hasConcept C2778170410 @default.
• W2008329181 hasConcept C2778690821 @default.
• W2008329181 hasConcept C502942594 @default.
• W2008329181 hasConcept C55493867 @default.
• W2008329181 hasConcept C67662055 @default.
• W2008329181 hasConcept C86803240 @default.
• W2008329181 hasConcept C8891405 @default.
• W2008329181 hasConceptScore W2008329181C147483822 @default.
• W2008329181 hasConceptScore W2008329181C149532602 @default.
• W2008329181 hasConceptScore W2008329181C153911025 @default.
• W2008329181 hasConceptScore W2008329181C154317977 @default.
• W2008329181 hasConceptScore W2008329181C202751555 @default.
• W2008329181 hasConceptScore W2008329181C203014093 @default.
• W2008329181 hasConceptScore W2008329181C2776090121 @default.
• W2008329181 hasConceptScore W2008329181C2778170410 @default.
• W2008329181 hasConceptScore W2008329181C2778690821 @default.
• W2008329181 hasConceptScore W2008329181C502942594 @default.
• W2008329181 hasConceptScore W2008329181C55493867 @default.
• W2008329181 hasConceptScore W2008329181C67662055 @default.
• W2008329181 hasConceptScore W2008329181C86803240 @default.
• W2008329181 hasConceptScore W2008329181C8891405 @default.
• W2008329181 hasIssue "1-2" @default.

• next